Arcturus Therapeutics Holdings Stock Price on September 26, 2024
| ARCT Stock | USD 17.51 0.58 3.43% |
Below is the normalized historical share price chart for Arcturus Therapeutics Holdings extending back to May 22, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Arcturus Therapeutics stands at 17.51, as last reported on the 28th of November, with the highest price reaching 17.72 and the lowest price hitting 16.92 during the day.
If you're considering investing in Arcturus Stock, it is important to understand the factors that can impact its price. Arcturus Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0487, which signifies that the company had a -0.0487% return per unit of standard deviation over the last 3 months. Arcturus Therapeutics Holdings exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Arcturus Therapeutics' mean deviation of 3.15, and Risk Adjusted Performance of (0.02) to double-check the risk estimate we provide.
At this time, Arcturus Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year. Common Stock Shares Outstanding is likely to gain to about 28 M in 2024, whereas Sale Purchase Of Stock is likely to drop slightly above 1.5 M in 2024. . At this time, Arcturus Therapeutics' Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 3.17 in 2024, whereas Price Earnings To Growth Ratio is likely to drop 0.06 in 2024. Arcturus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 16th of April 2020 | 200 Day MA 26.3321 | 50 Day MA 20.0822 | Beta 2.64 |
Arcturus |
Sharpe Ratio = -0.0487
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ARCT |
Estimated Market Risk
| 4.19 actual daily | 37 63% of assets are more volatile |
Expected Return
| -0.2 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Arcturus Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Arcturus Therapeutics by adding Arcturus Therapeutics to a well-diversified portfolio.
Price Book 1.7512 | Enterprise Value Ebitda (25.67) | Price Sales 2.957 | Shares Float 24.8 M | Wall Street Target Price 79.4678 |
Related Headline
Beam Therapeutics Headline on 26th of September 2024
Acquisition by Walsh Kathleen E of 16532 shares of Beam Ther... by Walsh Kathleen E
Filed transaction by Beam Therapeutics Director. Grant, award or other acquisition pursuant to Rule 16b-3
Arcturus Therapeutics Valuation on September 26, 2024
It is possible to determine the worth of Arcturus Therapeutics on a given historical date. On September 26, 2024 Arcturus was worth 21.72 at the beginning of the trading date compared to the closed value of 21.77. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Arcturus Therapeutics stock. Still, in general, we apply an absolute valuation method to find Arcturus Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Arcturus Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Arcturus Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 21.73 | 21.96 | 20.89 | 21.31 | 334,953 | |
09/26/2024 | 21.72 | 21.79 | 21.10 | 21.77 | 274,122 |
| 22.17 | 22.37 | 21.74 | 22.03 | 371,323 |
| Backtest Arcturus Therapeutics | | | Arcturus Therapeutics History | | | Arcturus Therapeutics Valuation | Previous | Next |
Arcturus Therapeutics Trading Date Momentum on September 26, 2024
| On September 27 2024 Arcturus Therapeutics Holdings was traded for 22.03 at the closing time. The top price for the day was 22.37 and the lowest listed price was 21.74 . The trading volume for the day was 371.3 K. The trading history from September 27, 2024 was a factor to the next trading day price appreciation. The overall trading delta against the next closing price was 1.19% . The overall trading delta against the current closing price is 8.91% . |
Arcturus Therapeutics Fundamentals Correlations and Trends
By evaluating Arcturus Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Arcturus Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Arcturus financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Arcturus Therapeutics Stock history
Arcturus Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Arcturus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Arcturus Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Arcturus Therapeutics stock prices may prove useful in developing a viable investing in Arcturus Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 26.6 M | 28 M | |
| Net Income Applicable To Common Shares | 8.4 M | 8.8 M |
Arcturus Therapeutics Quarterly Net Working Capital |
|
Arcturus Therapeutics Stock Technical Analysis
Arcturus Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Arcturus Therapeutics Period Price Range
Low | November 28, 2024
| High |
0.00 | 0.00 |
Arcturus Therapeutics Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Arcturus Therapeutics November 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Arcturus Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Arcturus Therapeutics shares will generate the highest return on investment. By undertsting and applying Arcturus Therapeutics stock market strength indicators, traders can identify Arcturus Therapeutics Holdings entry and exit signals to maximize returns
Arcturus Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Arcturus Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Arcturus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Arcturus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.33) | |||
| Total Risk Alpha | (0.79) | |||
| Treynor Ratio | (0.13) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Arcturus Stock Analysis
When running Arcturus Therapeutics' price analysis, check to measure Arcturus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcturus Therapeutics is operating at the current time. Most of Arcturus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Arcturus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcturus Therapeutics' price. Additionally, you may evaluate how the addition of Arcturus Therapeutics to your portfolios can decrease your overall portfolio volatility.